haemophilia
Sangamo and Pfizer’s gene therapy increases FVIII activity in severe haemophilia A in early study
April 3, 2019Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma
Sangamo Therapeutics and Pfizer have unveiled new Phase 1/2 data for their jointly developed investigational gene therapy SB-525, demonstrating that …
Roche scores two EU approvals in haemophilia and rare autoimmune disease
March 15, 2019Medical Communications EC, EU, Europe, Roche, haemophilia, rare diseases
The European Commission (EC) has approved Roche’s haemophilia treatment Hemlibra (emicizumab). The approval comes as the EC approved Roche’s MabThera …
Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors
March 14, 2019Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma
Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …
Pfizer’s biosimilar proves non-inferior to rituximab in lymphoma at ASH 2018
December 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASH 2018, Pfizer, haemophilia
Joining the chorus of data presentations at the American Society of Hematology (ASH) Annual Meeting 2018, Pfizer has announced new …
Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients
December 4, 2018Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma
In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …
Bayer’s Jivi approved in Europe for previously treated haemophilia A
November 28, 2018Research and Development, Sales and Marketing Bayer, Jivi, haemophilia, pharma
Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from …
FDA expands indication of Roche’s Hemlibra in haemophilia
October 5, 2018Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma
The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
Bayer to cut 227 positions in California to drive efficiency in haemophilia
October 4, 2018Manufacturing and Production Bayer, haemophilia, pharma
Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …
Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%
August 8, 2018Research and Development Spark Therapeutics, haemophilia, pharma
Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
Roche’s Hemlibra stakes claim to be haemophilia market leader
May 21, 2018Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …
Five deaths linked to Roche’s haemophilia drug Hemlibra
March 28, 2018Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma
Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …
Europe approves first therapy for haemophilia A with inhibitors in over 20 years
March 1, 2018Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma
Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …
Shire scores European approval for Adynovi in haemophilia A
January 15, 2018Sales and Marketing Adynovi, Europe, European Commission, Shire, haemophilia, haemophilia a, pharma
Shire has revealed that the European Commission has approved Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in …
Top Ten most popular articles on Pharmafile.com this week
December 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten
Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …
‘Mind-blowing’ gene therapy could herald a cure for haemophilia, study shows
December 14, 2017Research and Development haemophilia, pharma
A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
